Clinical Trials
10 trialsNCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT04460456 2022-06-30
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Phase 1 Unknown
NCT02675946 2022-01-26
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Curegenix Inc.
Phase 1 Unknown
NCT03507998 2020-07-24
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Curegenix Inc.
Phase 1 Unknown
NCT03474861 2018-03-26
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer
Hangzhou Converd Co., Ltd.
Phase 1 Unknown
NCT02513849 2017-05-09
Tamoxifen in Patients With Oesophageal Cancer
University of Nottingham
Phase 1 Unknown
NCT02512328 2015-07-30
PERICLESAPPI
Technical University of Munich
Phase 1 Unknown
NCT02169388 2014-06-25
Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
Shandong University
Phase 1 Unknown
NCT00710697 2009-09-24
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Phase 1 Unknown
NCT00506207 2007-07-25
TIROX
National Cancer Center, Korea
Phase 1 Unknown